Insulin Analogs Versus Human Insulin in the Treatment of Patients With Diabetic Ketoacidosis
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To compare the safety and efficacy of insulin analogs and human insulins both during acute intravenous treatment and during the transition to subcutaneous insulin in patients with diabetic ketoacidosis (DKA). RESEARCH DESIGN AND METHODS: In a controlled multicenter and open-label trial, we randomly assigned patients with DKA to receive intravenous treatment with regular or glulisine insulin until resolution of DKA. After resolution of ketoacidosis, patients treated with intravenous regular insulin were transitioned to subcutaneous NPH and regular insulin twice daily (n = 34). Patients treated with intravenous glulisine insulin were transitioned to subcutaneous glargine once daily and glulisine before meals (n = 34). RESULTS: There were no differences in the mean duration of treatment or in the amount of insulin infusion until resolution of DKA between intravenous treatment with regular and glulisine insulin. After transition to subcutaneous insulin, there were no differences in mean daily blood glucose levels, but patients treated with NPH and regular insulin had a higher rate of hypoglycemia (blood glucose <70 mg/dl). Fourteen patients (41%) treated with NPH and regular insulin had 26 episodes of hypoglycemia and 5 patients (15%) in the glargine and glulisine group had 8 episodes of hypoglycemia (P = 0.03). CONCLUSIONS: Regular and glulisine insulin are equally effective during the acute treatment of DKA. A transition to subcutaneous glargine and glulisine after resolution of DKA resulted in similar glycemic control but in a lower rate of hypoglycemia than with NPH and regular insulin. Thus, a basal bolus regimen with glargine and glulisine is safer and should be preferred over NPH and regular insulin after the resolution of DKA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Automated, computerized, IV insulin protocols, including commercially available or institutional-based protocols, have improved glycemic control, with good acceptance by nursing personnel.1294–1307”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1301]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266 · cited 1×
“In recent years, the use of long-acting basal and rapid-acting insulin analogs have been recommended as a more physiologic approach than NPH and regular insulin for glucose control in the hospital;(12; 13) however, no previous studies have evaluated the safety and efficacy of insulin analogs in the management of patie…”
BackgroundManagement of Hyperglycemic Crises in Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., Barrett, E. J., Kreisberg, R. A., Malone, J. I., & Wall, B. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.131 · Cited by 710 · cited 5×
“and substantial spending related to direct and indirect costs (2).”
BackgroundInfluentialSelf-citationSevere hypoglycemia in critically ill patients: risk factors and outcomes
Krinsley, J. S., & Grover, A. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000282073.98414.4b · Cited by 671 · cited 1×
“Minimizing the rate of hypoglycemia events is of major importance in hospitalized patients because it may represent an independent risk factor of poor clinical outcome (24).”
BackgroundUmpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Self-citationHyperglycemic Crises in Adult Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., & Kreisberg, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-9916 · Cited by 512
Self-citationManagement of Hyperglycemia in the Hospital Setting
Inzucchi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060094 · Cited by 391
Owens, D. R., Zinman, B., & Bolli, G. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05842-1 · Cited by 373 · cited 1×
“Glulisine has a faster onset of action and a shorter duration of action after subcutaneous injection compared with regular insulin (21,22).”
BackgroundMonomeric Insulins and Their Experimental and Clinical Implications
Brange, J., Owens, D. R., Kang, S., & Vølund, A. (1990) · Diabetes Care · doi:10.2337/diacare.13.9.923 · Cited by 369 · cited 1×
“Glulisine has a faster onset of action and a shorter duration of action after subcutaneous injection compared with regular insulin (21,22).”
BackgroundHyperglycemic Crises in Urban Blacks
Umpierrez, G. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.6.669 · Cited by 295 · cited 5×
“The rate of hypoglycemic events in this study is similar to the rate reported previously with the use of NPH and regular insulin after discontinuation of intravenous therapy (3,9).”
BackgroundMethodResultInfluentialSelf-citationVariability of Insulin Absorption and Insulin Action
Heinemann, L. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/152091502320798312 · Cited by 267 · cited 2×
“in absorption (11) partially explains the”
Background
Cited by
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
“30; bicarbonate "18 mmol/l) is corrected is 6 and 12 h, respectively (9,55).”
BackgroundResultSelf-citationUmpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
“8 mmol/liter) who are eating usual meals can have basal bolus insulin therapy initiated at a total daily dose based on body weight (33, 35, 75).”
BackgroundSelf-citationDiabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563
Self-citationBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationDhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0165-1 · Cited by 461
Self-citationThe evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management
Nyenwe, E. A., & Kitabchi, A. E. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.007 · Cited by 309
Management of Hyperglycemic Crises
Fayfman, M., Pasquel, F. J., & Umpierrez, G. E. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.12.011 · Cited by 278
Self-citationHyperglycemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0032 · Cited by 278
Self-citationDanne, T., Phillip, M., Buckingham, B. A., Jarosz-Chobot, P., Saboo, B., Urakami, T., Battelino, T., Hanas, R., & Codner, E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12718 · Cited by 225
Umpierrez, G. E., Smiley, D., Hermayer, K., Khan, A., Olson, D. E., Newton, C., Jacobs, S., Rizzo, M., Peng, L., Reyes, D., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1988 · Cited by 222
“…bene fi ts of a basal-bolus regimen in improving glycemic control in non-critically ill patients (2,7,9,10,14), many health care providers and hospital-ists are reluctant to integrate this approach into their clinical practice, probably because of its complexity and a fear of hypoglycemia (15 – 18).”
BackgroundSelf-citationHyperglycaemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06183-8 · Cited by 225
“For most patients with DKA, 20–30 mmol of potassium per litre of intravenous fluid is sufficient to maintain a serum potassium concentration within the target range.”
InfluentialSelf-citationManagement of Hyperglycemia During Enteral and Parenteral Nutrition Therapy
Gosmanov, A. R., & Umpierrez, G. E. (2013) · Current Diabetes Reports · doi:10.1007/s11892-012-0335-y · Cited by 166
Self-citationEvidence-based management of hyperglycemic emergencies in diabetes mellitus
Nyenwe, E. A., & Kitabchi, A. E. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.09.012 · Cited by 157
“[48] Umpierrez GE, Jones S, Smiley D, Mulligan P, Keyler T, Temponi A, et al.”
BackgroundCengiz, E., Danne, T., Ahmad, T., Ayyavoo, A., Beran, D., Ehtisham, S., Fairchild, J., Jarosz‐Chobot, P., Ng, S. M., Paterson, M., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13442 · Cited by 93
“Regular and rapid-acting and ultra-rapid insulins are equally suited for IV therapy.(160) Regular insulin has traditionally been used for IV infusion for inpatient management of diabetes.”
BackgroundManagement of diabetic ketoacidosis in adults: A narrative review
Elzouki, A.-N. Y., & Eledrisi, M. S. (2020) · Saudi Journal of Medicine and Medical Sciences · doi:10.4103/sjmms.sjmms_478_19 · Cited by 120
Review of evidence for adult diabetic ketoacidosis management protocols
Tran, T. T. T., Pease, A., Wood, A. J., Zajac, J. D., Mårtensson, J., Bellomo, R., & Ekinci, E. I. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00106 · Cited by 97
“Insulin analogs glulisine, aspart and lispro have been reported to have equal efficacy and in vivo potency compared to regular insulin in animals and humans, attributable to their similar receptor binding affinity and receptor mediated clearance (50–53), although only studies comparing the role of intravenous glulisin…”
BackgroundDiabetic ketoacidosis in adults
Misra, S., & Oliver, N. S. (2015) · BMJ · doi:10.1136/bmj.h5660 · Cited by 105
Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis
Andrade-Castellanos, C. A., Colunga-Lozano, L. E., Delgado-Figueroa, N., & Gonzalez-Padilla, D. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011281.pub2 · Cited by 71
Farrokhi, F., Klindukhova, O., Chandra, P., Peng, L., Smiley, D., Newton, C., Pasquel, F., Fereira, M. E., & Umpierrez, G. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600505 · Cited by 74
Self-citationDesse, T. A., Eshetie, T. C., & Gudina, E. K. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1495-z · Cited by 71
Chaudhuri, A., & Umpierrez, G. E. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.04.016 · Cited by 60
“Despite the use of low-dose insulin protocols, hypoglycemia is still reported in 10%–30% of patients with DKA (Umpierrez et al., 2009).”
BackgroundSelf-citationBueno, E., Benitez, A., Rufinelli, J., Figueredo, R., Alsina, S., Ojeda, A., Samudio, S., Cáceres, M., Argüello, R., Romero, F., et al. (2015) · Endocrine Practice · doi:10.4158/ep15675.or · Cited by 56
Self-citationEvaluation and Management of the Critically Ill Adult With Diabetic Ketoacidosis
Long, B., Willis, G. C., Lentz, S. A., Koyfman, A., & Gottlieb, M. A. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.06.059 · Cited by 57
Updates in the Management of Hyperglycemic Crisis
Aldhaeefi, M., Aldardeer, N. F., Alkhani, N., Alqarni, S. M., Alhammad, A., & Alshaya, A. I. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2021.820728 · Cited by 57
Ullal, J., Aloi, J. A., Reyes-Umpierrez, D., Pasquel, F. J., McFarland, R., Rabinovich, M., & Umpierrez, G. E. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817750899 · Cited by 49
“Typically, regular human insulin is the preferred intravenous insulin however, there have been studies demonstrating the use of analog insulin in DKA therapy.(9) There have been smaller retrospective studies in critically ill patients comparing nurse-driven computerized insulin infusion program and conventional paper-…”
Self-citationLee, M. H., Calder, G. L., Santamaria, J. D., & MacIsaac, R. J. (2018) · Internal Medicine Journal · doi:10.1111/imj.13735 · Cited by 47
Pasquel, F. J., Lansang, M. C., Khowaja, A., Urrutia, M. A., Cardona, S., Albury, B., Galindo, R. J., Fayfman, M., Davis, G., Migdal, A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1940 · Cited by 45
“Procedures Patients were treated with a basal-bolus insulin regimen approach as previously reported (see Supplementary Data) (9,12,21).”
MethodInfluentialSelf-citationCurrent Diagnosis and Treatment of Hyperglycemic Emergencies
Corwell, B. N., Knight, B., Olivieri, L., & Willis, G. C. (2014) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2014.01.004 · Cited by 54
Management of Hyperglycemia and Diabetes in the Emergency Department
Echouffo-Tcheugui, J. B., & Garg, R. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0883-2 · Cited by 49
Cardona, S., Gomez, P. C., Vellanki, P., Anzola, I., Ramos, C., Urrutia, M. A., Haw, J. S., Fayfman, M., Wang, H., Galindo, R. J., et al. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000607 · Cited by 38
“The study team collected information on: (1) admission service, admitting diagnosis and demographic information, (2) hyperglycemia treatment, (3) number of hypoglycemic episodes by point-of-care testing or laboratory during hospital stay following indexed event, (4) history of hypoglycemia before admission in the ambu…”
BackgroundSelf-citationAbegaz, T. M., Mekonnen, G. A., Gebreyohannes, E. A., & Gelaye, K. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264626 · Cited by 46
“This ultimately helps to lower the blood glucose below 250 mg/dL within 6 hours of initiation of treatment [11, 30, 31].”
BackgroundVincent, M., & Nobécourt, E. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.12.003 · Cited by 42
“N obécourt / D iabetes & M etabolism 39 (2013) 299–305 Table 1 (Continued ) Study (country) Studies in adult patients Paediatric patients Umpierrez et al., 2004 [9] (USA) Ersöz et al., 2006 [11] (Turkey) Karoli et al., 2011 [12] (India) della Manna et al., 2005 [10] (Brazil) Insulin arm Lispro…”
BackgroundMethodInfluentialDuggan, E. W., Klopman, M. A., Berry, A. J., & Umpierrez, G. E. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0720-z · Cited by 39
Self-citationHyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Umpierrez, G. E. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_21 · Cited by 43
Self-citationDiagnosis and management of hyperglycemic emergencies
Chaithongdi, N., Subauste, J. S., Koch, C. A., & Geraci, S. A. (2011) · HORMONES · doi:10.14310/horm.2002.1316 · Cited by 54
Adult Hyperglycemic Crisis: A Review and Perspective
Steenkamp, D., Alexanian, S. M., & McDonnell, M. E. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0342-z · Cited by 39
Controversies in the management of hyperglycaemic emergencies in adults with diabetes
Cardoso, L., Vicente, N., Rodrigues, D. M., Gomes, L., & Carrilho, F. (2016) · Metabolism · doi:10.1016/j.metabol.2016.11.010 · Cited by 43
Management of diabetic ketoacidosis in pregnancy
Mohan, M., Baagar, K. A. M., & Lindow, S. W. (2017) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12344 · Cited by 35
Diabetic Ketoacidosis: A Review and Update
Perilli, G., Saraceni, C., Daniels, M. N., & Ahmad, A. (2013) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-012-0001-3 · Cited by 34
Diabetic Ketoacidosis Management: Updates and Challenges for Specific Patient Population
El‐Remessy, A. B. (2022) · Endocrines · doi:10.3390/endocrines3040066 · Cited by 42
Diabetic Ketoacidosis in the Pediatric Emergency Department
Olivieri, L., & Chasm, R. M. (2013) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2013.05.004 · Cited by 35
Marshall, R. D., Rand, J. S., Gunew, M. N., & Menrath, V. H. (2013) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12038 · Cited by 31
Houshyar, J., Bahrami, A., & Aliasgarzadeh, A. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/12005.5883 · Cited by 32
“Diabetic Ketoacidosis (DKA) is one of emergency conditions caused by acute hyperglycemia which may be associated with both type 1 and 2 diabetes, mostly type 1 and is the cause for 10,000 to 160,000 hospitalizations in US [3-5].”
BackgroundHyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Umpierrez, G. E. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_21-1 · Cited by 30
Self-citationGalindo, R. J., Pasquel, F. J., Vellanki, P., Alicic, R., Lam, D. W., Fayfman, M., Migdal, A. L., Davis, G. M., Cardona, S., Urrutia, M. A., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14544 · Cited by 26
“Management of the insulin regimen was directed by the study team following a basal-bolus insulin regimen previously reported.(6-8,22,23) In brief, subjects treated with insulin before admission”
Self-citationAlkaabba, A., Alzuair, B. S., AlHarbi, Y. F., Alshehri, J. A., Allowaihiq, L. H., Alrashid, M. H., & Alkhatabi, R. A. (2021) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2021.115009 · Cited by 24
New approaches to the use of insulin in patients with diabetic ketoacidosis
Barski, L., Kezerle, L., Zeller, L., Zektser, M., & Jotkowitz, A. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.01.014 · Cited by 23
“) Based on these pharmacological similarities, Umpierrez and colleagues conducted a controlled multicenter, open-label prospective and randomized trial of 68 patients with DKAwhowere assigned to receive intravenous treatment with regular insulin or glulisine insulin until resolution of DKA [39].”
BackgroundMethodGalm, B. P., Bagshaw, S. M., & Senior, P. A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.11.003 · Cited by 26
Wang, Yu, Zhang, Floyd, Z. E., Lian, Cefalu, & Boudreau (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30887 · Cited by 22
“Differences among the four groups were tested using one-way analysis of variance and least-significant difference or Tamhane’s T2 tests.(24) A P value #0.”
Al-Azzawi, B. A., McGuigan, D. H., Koivula, F. N. M., Elttayef, A., Dale, T. P., Yang, Y., Kelly, C., & Forsyth, N. R. (2020) · The Open Stem Cell Journal · doi:10.2174/1876893802006010001 · Cited by 24
Inpatient dysglycemia and clinical outcomes: Association or causation?
Umpierrez, G. E., & Kosiborod, M. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.03.008 · Cited by 22
“, 2006) and 5% and 32% in non-ICU patients treated with subcutaneous insulin (Umpierrez et al., 2007; Umpierrez et al., 2009; Umpierrez et al., 2011).”
BackgroundInfluentialSelf-citationGalindo, R. J., Davis, G. M., Fayfman, M., Reyes-Umpierrez, D., Alfa, D., Peng, L., Tamler, R., Pasquel, F. J., & Umpierrez, G. E. (2017) · Endocrine Practice · doi:10.4158/ep171804.or · Cited by 21
Self-citationCengiz, E., Danne, T., Ahmad, T., Ayyavoo, A., Beran, D., Codner, E., Ehtisham, S., Jarosz-Chobot, P., Mungai, L. N. W., Ng, S. M., et al. (2025) · Hormone Research in Paediatrics · doi:10.1159/000543169 · Cited by 17
Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Umpierrez, G. E. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_21-2 · Cited by 17
Self-citationProlonged glucosuria and relapse of diabetic ketoacidosis related to SGLT2‐inhibitor therapy
Westcott, G. P., Segal, A., Mitri, J., & Brown, F. M. (2020) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.117 · Cited by 14
Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State in Cats
Rand, J. S. (2013) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2013.01.004 · Cited by 15
Edholm, K., Lappé, K., Kukhareva, P., Hopkins, C., Hatton, N. D., Gebhart, B. C., Nyman, H. A., Signor, E. A., Davis, M., Kawamoto, K., et al. (2020) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000247 · Cited by 15
“Despite multiple prior studies demonstrating safety and efficacy of frequent doses of short-acting insulin compared with a continuous insulin infusion in mild or moderate DKA, the mainstay of DKA treatment has remained continuous insulin infusion.(5-9) The reason for this is likely multifactorial.”
BackgroundMethodManagement of the Hospitalized Patient With Type I Diabetes Mellitus
Mendez, C. E., & Umpierrez, G. E. (2013) · Hospital Practice · doi:10.3810/hp.2013.08.1072 · Cited by 13
Self-citationHyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Umpierrez, G. E. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_21 · Cited by 12
Self-citationDiabetic ketoacidosis and hyperosmolar state
Kitabchi, A. E., Umpierrez, G. E., & Murphy, M. B. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch54 · Cited by 14
Self-citationHospital hypoglycemia: From observation to action
Bellam, H., & Braithwaite, S. S. (2010) · Insulin · doi:10.1016/s1557-0843(10)80007-7 · Cited by 13
Elsherif, I., Jammah, A. A., Ibrahim, A. R., Alawadi, F., Sadek, I. S., Rahman, A. M., Sharify, G. E., AlFeky, A., Aldossari, K. K., Roushdy, E., et al. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2024.06.003 · Cited by 11
Landgraf, R., Kellerer, M., Aberle, J., Fach, E.-M., Gallwitz, B., Hamann, A., Joost, H., Klein, H., Müller‐Wieland, D., Nauck, M. A., et al. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/a-0598-0475 · Cited by 18
Diabetologische Notfälle: Ketoazidose und hyperglykämes Koma
Schumann, C. Y., & Faust, M. (2018) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0043-114493 · Cited by 13
“Im Mittel dauert bei der DKA die Beseitigung der metabolischen Azidose (pH > 7,3; Bikarbonat > 18mmol/l) mit 12 Stunden 6 Stunden länger als die der Hyperglykämie (Blutzucker < 250mg/dl) [11, 12], weswegen Glukoseinfusionen notwendig sind, um eine weitere Insulintherapie ohne Hypoglykämie zu erlauben.”
BackgroundSafety of Rapid-Acting Insulin Analogs Versus Regular Human Insulin
Kitabchi, A. E., & Gosmanov, A. R. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182449ff9 · Cited by 11
Management of diabetic ketoacidosis and hyperglycemic hyperosmolar state in adults
Anzola, I., Gomez, P., & Umpierrez, G. E. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2016.1145049 · Cited by 10
Self-citationLorenson, J., Cusumano, M. C., Stewart, A. M., Buhnerkempe, M., & Sanghavi, D. (2019) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12525 · Cited by 9
“to hypoglycaemia rates of 5%, 5%, 7%, 8% and 18%.([4,9,10,12,18]) A non-weight-based protocol using a rate reduction to 3 units/h reported an 8% incidence.”
BackgroundRisk Factors for Hypoglycemia During Treatment of Hyperglycemic Crises
Ross, R. C., Vadakkel, N., Westmoreland, K., Hendrickson, A. L., Balazh, J. R., Telford, E. D., & Franck, A. J. (2022) · Diabetes Spectrum · doi:10.2337/ds21-0094 · Cited by 8
Woode, D. E., & Kitabchi, A. E. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-256-8_14 · Cited by 8
Evaluation of Ward Management of Diabetic Ketoacidosis
Nemecek, B. D., Hermayer, K. L., Arnold, P. C., & Bohm, N. M. (2014) · Clinical Diabetes · doi:10.2337/diaclin.32.3.100 · Cited by 7
Udwadia, F., Bhattacharyya, A., Seshiah, V., Sethi, B. K., Kumar, S., Subbanna, P. K., Shetty, R., & Moses, A. (2012) · Diabetes Management · doi:10.2217/dmt.12.10 · Cited by 6
Berndt, M., & Lehnert, H. (2014) · Der Diabetologe · doi:10.1007/s11428-014-1266-9 · Cited by 6
Proumen, R., & Acharya, R. (2021) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2021.115026 · Cited by 7
“Various types of insulin have a similar serum profile when given intravenously [67] [77].”
BackgroundUmpierrez, G. E. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_41 · Cited by 7
Self-citationTang, C., & Kouides, R. W. (2014) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.3402/jchimp.v4.25755 · Cited by 6
“This approach was shown to be associated with a lower rate of hypoglycemic events (3).”
BackgroundUrgences métaboliques du diabète sucré
Lemoël, F., Mion, C., & Levraut, J. (2011) · EMC - Médecine d urgence · doi:10.1016/s1959-5182(11)38159-7 · Cited by 7
Optimizing Inpatient Glycemic Control with Basal-Bolus Insulin Therapy
Pollom, R. D. (2010) · Hospital Practice · doi:10.3810/hp.2010.11.346 · Cited by 5
Devi, R., Selvakumar, G., Clark, L., Downer, C., & Braithwaite, S. S. (2011) · Diabetes Management · doi:10.2217/dmt.11.18 · Cited by 6
Ciafardini, A., Vena, W., Betella, N., Pigni, S., Mirani, M., Altieri, V. M., Mazziotti, G., Lania, A. G., & Bossi, A. C. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303374972250407065308 · Cited by 5
Diabetes mellitus in der Anästhesie – optimale perioperative Blutzuckerkontrolle
Alscher, F., Friesenhahn‐Ochs, B., & Hüppe, T. (2021) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-1154-6944 · Cited by 4
“Daher sollten nach i. v. Insulingabe Kalium- und Blutzucker immer zeitgleich – nach ca. 15–30 min (maximaler Wirkeffekt) – mittels Blutgasanalyse bestimmt werden.”
BackgroundInfluentialVidyasagar, K., Chandrasekar, B., Chhabra, M., Bhansali, A. K., & Bansal, D. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.06.017 · Cited by 4
Comparative efficacy and safety of insulin analogs in hospitalized adults
Singh, K., Ansari, M., Patel, R. V., Bédard, M., Keely, E., Tierney, M., & Moher, D. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140161 · Cited by 4
Durán, S., Rivas, M. A. P., & Pérez, A. (2016) · Cited by 3
Effective Management of Diabetic Ketoacidosis
Cho, D. H. (2018) · Journal of Korean Diabetes · doi:10.4093/jkd.2018.19.4.208 · Cited by 3
“208 212 투여군에서는 15%에서만 저혈당을 경험하여 차이를 보였 다[19].”
Cantero, A. P., Sampalo, A. L., Quirantes, P. L., & Jansen‐Chaparro, S. (2020) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2020.09.022 · Cited by 4
Hyperglycemic Crises: Diabetic Ketoacidosis
Moazzami, B., Zabala, Z. E., & Umpierrez, G. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_44 · Cited by 4
Self-citationEvaluation of NovoRapid infusion as a treatment option in the management of diabetic ketoacidosis
Kwok, R., Sztal‐Mazer, S., Hopkins, R. E., Poole, S. G., Grannell, L., Coutsouvelis, J., & Topliss, D. J. (2017) · Internal Medicine Journal · doi:10.1111/imj.13607 · Cited by 2
IV Insulin Infusions: How to Use an “Insulin Drip”
Mabrey, M., & Lien, L. F. (2010) · Springer eBooks · doi:10.1007/978-1-60761-006-9_3 · Cited by 2
Acute Hyperglycemic Syndromes: Diabetic Ketoacidosis and the Hyperosmolar State
Feng, Y., & Fleckman, A. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_18 · Cited by 2
Hyperglycemic crises in diabetes mellitus. Current aspects
Neto, D. L., Pires, A. C., Revisão, A. D., & Carvalho, R. F. I. (2010) · Cited by 2
Hyperglycaemic crises in adult patients with diabetes mellitus
Kitabchi, A. E., & Nyenwe, E. A. (2011) · doi:10.1093/med/9780199235292.003.1460 · Cited by 6
Diabetisches Koma und perioperative Diabetestherapie
Berndt, M., Klose, S., & Lehnert, H. (2014) · Springer eBooks · doi:10.1007/978-3-642-54953-3_67 · Cited by 2
Prolonged diabetic ketoacidosis due to SGLT2 inhibitor use and low‐carbohydrate diet
Mung, S. M., Fonseca, I., Azmi, S., & Balmuri, L. M. R. (2023) · Practical Diabetes · doi:10.1002/pdi.2446 · Cited by 2
An Approach to Diabetic Ketoacidosis in an Emergency Setting
Pitocco, D., Leo, M. A. S. D., Tartaglione, L., Rizzo, E. G., Caputo, S., Rizzi, A., & Pontecorvi, A. (2020) · Reviews on Recent Clinical Trials · doi:10.2174/1574887115666200709172402 · Cited by 3
Type 1 Diabetes in 2023 - From Real Practice to Open Questions
Chlup, R. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100991 · Cited by 1
Correa-Guerrero, J., Garizabalo, E. R., Simanca, J. D. B., Santander, H. C., Assis, F. M. C., Arrieta, L. R., Pinedo, A. C., & Castell, C. R. D. (2026) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2026.100611 · Cited by 1
Diabetisches Koma und perioperative Diabetestherapie
Klose, S., & Lehnert, H. (2004) · Springer eBooks · doi:10.1007/978-3-662-06654-6_51 · Cited by 1
Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar State (HHS): Diabetes Emergencies
Skamagas, M., & Rule, E. (2012) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814354912_0047 · Cited by 1
Pharmaceutical Biotechnology: The Arrival of Recombinant Proteins
Banga, A. K. (2015) · CRC Press eBooks · doi:10.1201/b18392-4 · Cited by 1
Pasquel, F. J., & Umpierrez, G. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00046-9 · Cited by 1
Self-citation
Metadata
- Authors
- Umpierrez, G. E., Jones, S., Smiley, D., Mulligan, P., Keyler, T., Temponi, A., Semakula, C., Umpierrez, D., Peng, L., Cerón, M., & Robalino, G.
- Affiliations
- Emory University (US)
- University of Minnesota (US)
- Department of Medicine, Emory University School of Medicine, Atlanta, Georgia;
- Corresponding author
- Umpierrez, Guillermo E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-04-14
- Volume
- 32
- Issue
- 7
- Pages
- 1164-1169
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2699711
- OpenAlex
- W2123006117
- Cited by
- 120
- References
- 25
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 9 · 2021: 4 · 2020: 12 · 2019: 4 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 12 · 2014: 7 · 2013: 7 · 2012: 12
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association (7-03-CR-35)
- Sanofi
- National Institutes of Health (UL1TR000454)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK074556)
- National Center for Research Resources (M01-RR00039, M01RR000039)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- diabetic ketoacidosis, insulin analogues, regular insulin, NPH insulin, insulin glargine, multiple daily insulin injections, hypoglycemia, glycemic control, intravenous insulin therapy
- MeSH terms
- Adult, Blood Glucose, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin, Isophane, Male, Middle Aged, Patient Compliance, Recombinant Proteins, Diabetic Ketoacidosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.